357 filings
Page 12 of 18
6-K
TRIL
Trillium Therapeutics Inc.
9 Feb 18
Trillium Therapeutics to Present at Investor and Scientific Conferences In the First Quarter
12:00am
SC 13G/A
Janus Capital Management LLC
6 Feb 18
Trillium Therapeutics Inc.
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
17 Jan 18
Current report (foreign)
12:00am
F-10/A
TRIL
Trillium Therapeutics Inc.
8 Jan 18
Registration of securities (Canada) (amended)
12:00am
EFFECT
TRIL
Trillium Therapeutics Inc.
8 Jan 18
Notice of effectiveness
12:00am
F-10/A
TRIL
Trillium Therapeutics Inc.
8 Jan 18
Registration of securities (Canada) (amended)
12:00am
F-10
TRIL
Trillium Therapeutics Inc.
15 Dec 17
Registration of securities (Canada)
12:00am
F-X
TRIL
Trillium Therapeutics Inc.
15 Dec 17
Appointment of agent for service of process by issuers registering securities
12:00am
D
TRIL
Trillium Therapeutics Inc.
12 Dec 17
$19.98M in equity, sold $19.98M, 2 investors
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
11 Dec 17
Trillium Therapeutics Provides Update on Its TTI-621 Program at the American Society of Hematology 59TH Annual Meeting
12:00am
SC 13G
TRIL
Trillium Therapeutics Inc.
8 Dec 17
Trillium Therapeutics Inc.
12:00am
SC 13D/A
Growth Equity Opportunities V, LLC
5 Dec 17
Trillium Therapeutics Inc.
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
4 Dec 17
Trillium Announces Closing of Private Placement
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
20 Nov 17
Trillium Therapeutics’ TTI-2341 Egfr Inhibitor Program Featured at the Society for Neuro-oncology 22ND Annual Meeting
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
15 Nov 17
Trillium Announces Private Placement
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
15 Nov 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
13 Nov 17
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
13 Nov 17
Interim Condensed Consolidated Financial Statements
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
6 Nov 17
Trillium Therapeutics to Present at Upcoming Scientific Conferences
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
16 Oct 17
Trillium Therapeutics’ TTI-621 Program Featured at the Eortc CLTF Cutaneous Lymphoma Conference
12:00am